SkinStylus Wins FDA Clearance for Periorbital Wrinkles Across All Skin Types

SkinHealth Systems secured FDA clearance on July 17, 2026, for the SkinStylus SteriLock MicroSystem to treat periorbital wrinkles, giving practices a cleared microneedling option for under-eye aging across all Fitzpatrick skin types. This regulatory clearance, supported by clinical data presented at the 2026 SCALE Annual Meeting, establishes the device as the only microneedling system FDA-cleared for three distinct indications (facial acne scars, periorbital wrinkles, and abdominal scars) in adults aged 22 and older.

For your clinic, this clinical versatility translates directly to improved utility. Instead of navigating off-label risks or managing different systems for distinct body areas, you can leverage a single platform to address common structural issues from the face to the abdomen. Dermatologists like Dr. Glynis Ablon have noted that these multiple cleared indications support broader clinical utility, while manufacturer leadership points to the update as a move to compete directly in the premium microneedling market. If you are looking to simplify your technology stack while maintaining compliance across diverse patient demographics, this device presents a strong case for your next capital investment.

Source: Longevity.Technology, https://longevity.technology/lifestyle/skinstylus-secures-new-fda-win-for-healthier-skin-aging/